Clinical Trial Update: A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II clinical trial evaluating camrelizumab and apatinib plus GP in locally advanced or metastatic biliary tract cancer; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced Biliary Tract Cancer, Metastatic Biliary Tract Cancer | Phase 1, Phase 2 | Status: UNKNOWN